Menorrhagia


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

menorrhagia

[‚men·ə′rā·jē·ə]
(medicine)
Excessive bleeding during menstruation. Also known as hypermenorrhea.

Menorrhagia

 

profuse and protracted menstruation in which the menstrual cycle is preserved but the amount of blood lost during each period is greater than normal.

Menorrhagia is caused by decreased contractility of the uterine musculature. It occurs with chronic diseases of the uterus (metritis), acute inflammation of the adnexa uteri, uterine fibromyoma, and other gynecopathies. It can also result from blood diseases that reduce coagulability. Menorrhagia is treated by eliminating its primary causes.

References in periodicals archive ?
This is because the QALY for each intervention primarily was calculated by the duration of the recovery period, post-surgery, for the surgical arms of the study, and the duration of menorrhagia and resolved menorrhagia.
They assessed the effect of menorrhagia on six domains of daily life--practical difficulties, social life, psychological health, physical health, work and daily routine, and family life and relationships--using the condition-specific Menorrhagia Multi-Attribute Scale (MMAS).
The new Genesys HTA System has streamlined the procedure set-up and provides my patients an effective means to address their menorrhagia," said Christopher Guyer, M.
Menorrhagia may interfere significantly with quality of life and lead to complications such as iron deficiency as well as increased rates of procedures such as hysterectomy (with potential postoperative complications in an undiagnosed bleeder).
In the UK menorrhagia affects 22 per cent of the population of otherwise healthy, pre-menopausal women aged over 35.
The RCOG published its own clinical guidelines on the treatment of menorrhagia in the late 1990s.
This in turn leads to improved management of menorrhagia.
Surgical alternatives to hysterectomy for menorrhagia involve removing or destroying the uterine lining.
Because of its invasive nature, which leads to high cost and long patient recovery periods, hysterectomy has been reserved as a last-resort treatment for conditions like menorrhagia and uterine fibroids.
Previous studies gauging the effectiveness of various treatments for menorrhagia have focused on their control of menstrual blood loss, but there is great discordance between objective measures of blood loss and women's perception of the amount they bleed.
The FDA has approved Lysteda, an oral form of tranexamic acid, for the treatment of menorrhagia.